Literature DB >> 34216733

Strengthening capacity for clinical research in sub-Saharan Africa: partnerships and networks.

Thomas Nyirenda1, Moses Bockarie2, Shingai Machingaidze2, Michelle Nderu2, Michelle Singh2, Nuraan Fakier2, Jean-Marie Habarugira3, Pauline Beattie3, Lara Pandya3, Dominika Jajkowicz3, Yazdan Yazdanpanah4, Catherine Hankins5, Michael Makanga3.   

Abstract

Global research collaboration, through partnerships and networks, is an effective way to deliver highly impactful and sustainable research that is collectively owned and promoted for the global good. Many models exist for effective North-South collaborations that are built on trust and balanced benefits. The European & Developing Countries Clinical Trials Partnership (EDCTP) model emphasises capacity development in clinical trials and product-focused implementation research. To ensure effectiveness and sustainability, capacity development requires a long-term perspective, an integrated system-wide approach, and local ownership and leadership from countries experiencing high disease burdens. Guided by these principles, the EDCTP2 programme, established in 2014, has developed and strengthened human capital and institutional capacities in 39 countries in sub-Saharan Africa to undertake high-quality clinical research guided by good clinical and regulatory practices. Projects in these countries have involved 238 African and 163 European institutions. To date, EDCTP has supported 171 Fellows and 232 postgraduate trainees. EDCTP-short-term training activities have equipped 9628 researchers and medical personnel. The EDCTP capacity-building described here includes its Regional Networks of Excellence and its Consortia for public health emergencies which provide the foundation for sustained efforts against emerging and re-emerging global health threats.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Year:  2021        PMID: 34216733     DOI: 10.1016/j.ijid.2021.06.061

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Enabling research capacity strengthening within a consortium context: a qualitative study.

Authors:  Abiola Aiyenigba; Pierre Abomo; Neele Wiltgen Georgi; Imelda Bates; Justin Pulford
Journal:  BMJ Glob Health       Date:  2022-06

2.  Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.

Authors:  Francine Ntoumi; Eskild Petersen; Peter Mwaba; Eleni Aklillu; Sayoki Mfinanga; Dorothy Yeboah-Manu; Markus Maeurer; Alimuddin Zumla
Journal:  Int J Infect Dis       Date:  2022-03-14       Impact factor: 3.623

3.  Leveraging WHO's Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model.

Authors:  Solomon Owusu Sekyere; Ivana Škrnjug-Yudov; Ulysse Ateba Ngoa; Marcela Juárez Hernández; Onome T Abiri; James P Komeh; Markieu Janneh Kaira; Essa Marenah; Juwe Darnuwele Kercula; Keturah Smith; Olga Rassokhina; Heidi Meyer; Christoph Conrad
Journal:  Global Health       Date:  2022-06-20       Impact factor: 10.401

4.  Capacity Building in Sub-Saharan Africa as Part of the INTENSE-TBM Project During the COVID-19 Pandemic.

Authors:  A Calmy; F Bonnet; J Ambrosioni; E Ariza-Vioque; F Ello; H Andriamamonjisoa; V Machault; J González-Martín; M C Calvo-Cortés; S Eholié; G A Tchabert; T Ouassa; M Raberahona; R Rakotoarivelo; H Razafindrakoto; L Rahajamanana; R J Wilkinson; A Davis; M Maxebengula; F Abrahams; C Muzoora; N Nakigozi; D Nyehangane; D Nanjebe; H Mbega; R Kaitano; M Bonnet; P Debeaudrap; J M Miró; X Anglaret; N Rakotosamimanana
Journal:  Infect Dis Ther       Date:  2022-06-29

5.  A framework for managing health research capacity strengthening consortia: addressing tensions and enhancing capacity outcomes.

Authors:  Nadia Tagoe; Justin Pulford; Sam Kinyanjui; Sassy Molyneux
Journal:  BMJ Glob Health       Date:  2022-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.